A Descent into the Nuage: The Maelstrom of Transposon Control  by O'Donnell, Kathryn A. et al.
metastasis (Padera et al., 2008). These
data suggest that even combined block-
ade of VEGFR-2 and VEGFR-3 may not
be adequate.
Tammela et al. show that dual target-
ing prunes more vessels than targeting
VEGFR-2 or -3 alone. However, even
with this increased antivascular effect,
the tumors do not regress. Thus, tumor re-
gression and total eradication will require
the addition of drugs and/or radiation
that destroy cancer cells directly. It is in-
teresting to note that blocking VEGFR-2
normalizes the abnormal vessels in skin
adenovirally transduced with VEGF and
VEGF-C, similar to what is seen in some
tumors treated with this same anti-
VEGFR-2 antibody (Jain, 2005). Further-
more, blocking both VEGFR-2 and 3
with antibodies makes these angiogenic
skin vessels look even more normal, like
the control vasculature (Tammela et al.,
2008). So it is probable that dual targeting
will lead to a tumor vasculature more effi-
cient for drug and oxygen delivery, mak-
ing these tumors more vulnerable to che-
motherapy and radiation (Jain, 2005). The
challenge will be to identify the optimal
dose and schedule of these agents for
different tumors.
In conclusion, Tammela et al. have
linked the Notch pathway to the produc-
tion of an abnormal tumor vasculature
through the control of VEGFR-3 expres-
sion on endothelial tip cells and its role
in endothelial sprouting. It is important to
test if targeting VEGFR-3 in tumors can
improve the outcome of combined anti-
VEGF/VEGFR-2 and cytotoxic therapies
and lead to longer progression-free and
overall survival.
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In this issue of Developmental Cell, Soper et al. (2008) report that the mammalian MAELSTROM (MAEL) pro-
tein is critical for transposon silencing in the male germline. Loss of MAEL is associated with meiotic failure
and DNA damage, suggesting that efficient transposable element restraining mechanisms must be in place
for the preservation of germline integrity.Sexually reproducing species face the
daunting challenge of transmitting their
genetic material to subsequent genera-
tions without the accumulation of muta-
tions or major genomic alterations. Since
the discovery of transposable elements
(TEs) by Barbara McClintock 60 years
ago, it has been recognized that these
mobile sequences pose a considerable
threat to genomic integrity duringgermlinetransmission. It is therefore not surpris-
ing that diversemechanismshave evolved
to silence germline TE mobilization. A
paper by Soper et al. (2008) in this issue
of Developmental Cell reveals the im-
portance of the MAELSTROM protein
in transposon control and highlights
the danger posed by mobile elements
when left unchecked in the mammalian
germline.Developmental Cell 1DNA methylation is one well-under-
stood mechanism of TE silencing. Re-
cently, a novel transposon-silencing path-
way reliant on small RNAs has attracted
much attention (Aravin et al., 2007). At
the center of this pathway is a class of
small RNAs (termed piRNAs) that bind
thegermline-specific ‘‘Piwi’’ classofArgo-
naute proteins. Many of these piRNAs
are complementary to mobile elements.5, August 12, 2008 ª2008 Elsevier Inc. 179
Developmental Cell
PreviewsFigure 1. The Three Phases of Spermatogenesis in Mice: Mitosis, Meiosis, and
Spermiogenesis
Duringmitosis, stem cells divide to generate primary spermatocytes. These proceed throughmeiosis I and
II to generate haploid round spermatids. Meiotic prophase I is further divided into several stages: in
leptotene spermatocytes (LSc), chromosomes condense and sister chromatids pair. In zygotene sper-
matocytes (ZSc), synaptonemal complex components are organized for pairing of homologs. Crossover
occurs in pachytene spermatocytes (PSc), resulting in the exchange of genetic information. Homologous
chromosomes separate in diplotene and resolve in diakinesis. During spermiogenesis, after the second
meiotic division, round spermatids mature to elongated forms and spermatozoa. Meiotic arrest points
are indicated for mouse Maelstrom and Piwi family mutants.Mutations in two mouse Piwi members,
Mili (Piwil2) and Miwi2 (Piwil4), result in
the loss of TE DNA methylation in the tes-
tes (Kuramochi-Miyagawa et al., 2008).
These findings suggest that small RNAs
guide the methylation machinery to trans-
posable elements in the germline to medi-
ate silencing. Recently, the mouse MAEL-
STROM protein was found to interact
with two Piwi proteins, MILI (PIWIL2) and
MIWI (PIWIL1), in the germline-specific
structure called nuage (Costa et al.,
2006), hinting that MAEL may function in
this pathway.
Nuage (‘‘cloud’’ in French) is a perinu-
clear electron-dense structure found in
germline cells of many species. Its func-
tion, however, has remained mysterious.
Similar to P bodies in somatic cells, the
germline-specific nuage is enriched for
multiple components of the small RNA si-
lencing pathway, including the helicases
Armitage and Spindle-E and the Piwi pro-
teins Argonaute3 and Aubergine in flies,
ZIWI in zebrafish, and MILI and MIWI in
mice (Klattenhoff and Theurkauf, 2008).
Recent studies have established a con-
nection between members of the Piwi
pathway and transposon control. More-180 Developmental Cell 15, August 12, 2008over, derepression of retrotransposons
was observed in two Drosophila nuage
component mutants, maelstrom and
krimper (Lim and Kai, 2007), suggesting
that the nuage coordinates activity of the
RNA silencing pathway in TE control in
the Drosophila germline.
In flies, Maelstrom is expressed in the
female germline, yet its biochemical func-
tion remains undefined. It was originally
identified based on is role in oocyte
axis specification (Clegg et al., 1997; Find-
ley et al., 2003). The name refers to thedis-
torted appearanceofmicrotubules inmael
mutant oocytes. However, subsequent
studies suggested that the patterning
phenotype is a secondary consequence
of DNA damage checkpoint activation
(Klattenhoff and Theurkauf, 2008). Recent
work demonstrated that Mael is required
for the accumulation of repeat-associated
siRNAs (rasiRNAs) and repression of TEs
in flies (Lim and Kai, 2007).
Until now, it remainedunknownwhether
the mammalian counterpart of nuage and
MAELSTROM protein(s) function in trans-
poson silencing in the germline. In mam-
mals, MAEL is expressed in the male
germline. Soper et al. (2008) first exam-ª2008 Elsevier Inc.ined the localization ofMAELduring sper-
matogenesis (Figure 1). They observed
a stage-specific recruitment of MAEL to
nuage during the late pachytene and
diplotene stages.
To investigate the role of the mamma-
lian ortholog of MAEL in germline devel-
opment, a null allele of Mael was gener-
ated in mice. Elimination of Mael led to
germ cell degeneration in the testes and
male sterility. Mutant spermatocytes fail
to mature beyond zygotene of meiotic
prophase I and are eliminated by apopto-
sis by midpachytene. Furthermore, ex-
amination of chromosomepairing reveals
that MAEL is essential for meiotic chro-
mosome synapsis. In contrast to Dro-
sophila Maelstrom, expression of the
mammalian ortholog has not been dem-
onstrated during oogenesis, and nomen-
tion is made of a female infertility pheno-
type inMael null mice.
Interestingly, theMaelmutants undergo
meiotic arrest at the same point in sper-
matogenesis as Miwi2 and Mili mutants,
suggesting a functional relationship be-
tween these proteins. This led the authors
to ask whether MAEL is required for
piRNAbiogenesis.Maelmutantsarecom-
petent for production of prepachytene
piRNAs, which target repeat elements,
indicating that MAEL is dispensable for
piRNAexpression and accumulation. Sub-
sequent pachytene piRNAs are not ex-
pressed, presumably reflectingmeiotic cri-
sis and germ cell loss. These data do not
support a primary role for MAEL in piRNA
processing, although additional studies
may shed a brighter light on this issue.
A fascinatingconsequenceof the lossof
Mael is a dramatic increase in expression
of LINE-1 (L1) retrotransposons in adult
mutant testes relative toWT, asmeasured
by RT-PCR. Moreover, activation of L1
correlated with impairment of DNA meth-
ylation, reminiscent of the Mili and Miwi2
mutant phenotypes (Kuramochi-Miya-
gawa et al., 2008). A significant increase
in L1 ORF1p, which encodes a structural
protein required for retrotransposition,
was also observed. Expression of L1 in
the nucleus led to extensive DNAdamage,
evidenced by colocalization of ORF1p
and gH2AX, a marker of double-strand
breaks (DSBs). This is consistent with re-
ports demonstrating that overexpression
of L1 resulted in the accumulation of
gH2AX foci and DSBs in cell culture (Ga-
sior et al., 2006).
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series of experiments to distinguish DSBs
that occur normally during meiosis and
DNA damage that occurs inMael /mu-
tants. SPO11 is a topoisomerase that
generates DSBs during meiosis. In con-
trast to mice that lack Spo11 alone,
double-mutant mice lacking both Spo11
and Mael show massive gH2AX signal in
meiotic nuclei. These findings provide ev-
idence that the DSBs inMael /mutants
are independent of normal breaks that
facilitate genetic recombination.
Soper et al. (2008) have demonstrated
that the mammalian MAELSTROM pro-
tein is essential for silencing of retrotrans-
posons and provide evidence that early
meiosis is a critical time point when trans-
poson control is ensured in the male
germline. Many questions remain. Since
prepachytene piRNAs accumulate to nor-
mal levels in Mael mutants, MAEL likely
functions downstream of piRNA biogene-
sis and perhaps piRNA-Piwi complex
assembly. Instead, MAEL may function
at a later step such as shuttling Piwi com-
plexes from the nuage to sites of TEmeth-
ylation, as Soper et al. speculate. Indeed,
MAEL localization is dynamic, shuttling
from nuage to the nucleus (Findley et al.,
2003). It will thus be important to examine
the localization of Piwi proteins in Mael
mutants. The authors also suggest thatMAEL may play a more prominent role in
MIWI2-dependent processes based on
the similarity between their mutant pheno-
types. MAELSTROM interacts with MILI
and MIWI, however, additional studies
are necessary to determine whether
MAEL associates with MIWI2. Perhaps
most importantly, the primary cause of
DNA damage and meiotic failure in Mael
mutants remains elusive. Is it solely driven
by mobilization of TEs or could there be
other consequences of Maelstrom loss?
If it is the former, what burden of transpo-
son activity can be tolerated during meio-
sis? A lesser compromise of TE silencing
mechanisms (i.e., hypomorphic alleles of
Mael or Piwi family members) or circum-
vention of the meiotic crisis phenotype,
coupled with availing technologies for
endogenous transposon mapping, may
provide a newmeans for forward genetics
in mice. Finally, conspicuously lacking is
an understanding of TE silencing in mam-
malian oogenesis, which appears resis-
tant to meiotic failure in several mouse
models (Hunt and Hassold, 2002). De-
spite many unanswered questions, the
emerging story of nuage function draws
our attention to possible threats trans-
posable elements pose when not effi-
ciently silenced. Much like the chaos
created by the infamous whirlpool de-
scribed in Poe’s essay ‘‘A Descent intoDevelopmental Cell 1the Maelstrom,’’ inappropriate transpo-
son activation may well wreak havoc in
the germline.
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